Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
news_6

Trastuzumab Deruxtecan Type II Variation Application Validated by EMA for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen

Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by...

news_6

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy

First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination KENILWORTH, N.J. & TOKYO--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as...

news_6

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan

Japan’s Ministry of Health, Labor and Welfare Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection Molnupiravir, First Oral COVID-19 Antiviral...

news_6

Wavin, Orbia’s Building & Infrastructure Business, Joins Forces with Vectus to Provide the Indian Market with Access to Water and Sanitation Solutions

NEW DELHI--(BUSINESS WIRE)--Wavin B.V., a global solutions leader for the Building and Infrastructure industry and an Orbia business, announced today...